維力醫療(603309.SH):目前生產經營情況正常,產能飽和度較高
格隆匯11月22日丨維力醫療(603309.SH)在投資者互動平台表示,公司目前生產經營情況正常,產能飽和度較高。公司一直持續在北美和歐洲拓展新的大客户定製化項目,目前在研的海外大客户項目有20個左右,今年落地的大客户項目有3個,隨着前期交付磨合期的完成,逐步實現穩定發貨。今年第三季度,外銷業務快速恢復並實現同比增長。受國內行業政策環境影響,第三季度國內新產品進院和新產品放量受到一定程度影響,四季度以來影響在逐漸減弱。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.